BIO-TECHNE CORP's ticker is TECH and the CUSIP is 09073M104. A total of 549 filers reported holding BIO-TECHNE CORP in Q1 2022. The put-call ratio across all filers is 0.27 and the average weighting 0.2%.
About BIO-TECHNE CORP
Bio-Techne Corp is a leading provider of innovative life science research tools and diagnostic solutions. The company is headquartered in Minneapolis, Minnesota, and has operations in over 50 countries worldwide. Bio-Techne's products and services are used by researchers and clinicians in a wide range of fields, including cancer research, stem cell research, and immunology.
Bio-Techne's success is due in large part to its commitment to innovation and customer service. The company invests heavily in research and development, and has a team of over 1,000 scientists working to develop new products and technologies. Bio-Techne also has a strong focus on customer service, with a dedicated team of technical support specialists available to assist customers with any questions or issues they may have.
In addition to its research tools and diagnostic solutions, Bio-Techne also has a growing portfolio of clinical diagnostic products. The company's Exosome Diagnostics subsidiary is a leader in the development of liquid biopsy tests for cancer diagnosis and monitoring.
Bio-Techne's leadership team is comprised of experienced executives with a track record of success in the life sciences industry. Charles Kummeth, the company's CEO, has been with Bio-Techne since 2013 and has overseen significant growth and expansion during his tenure.
Overall, Bio-Techne is a company with a strong reputation for innovation, customer service, and leadership in the life sciences industry. With a growing portfolio of products and services, the company is well-positioned for continued success in the years to come.
It's important to note that this information is for educational purposes only and has not been fact-checked. As with any investment, it's important to do your own research and consult with a financial advisor before making any investment decisions.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $154,880,694 | -10.3% | 2,329,033 | +9.4% | 0.26% | -0.8% |
| Q2 2023 | $172,747,141 | +25.5% | 2,129,001 | +14.8% | 0.26% | +23.0% |
| Q1 2023 | $137,618,963 | -6.0% | 1,854,953 | +5.0% | 0.21% | -13.1% |
| Q4 2022 | $146,458,492 | +25.7% | 1,767,115 | +330.8% | 0.24% | +22.5% |
| Q3 2022 | $116,501,000 | -12.9% | 410,216 | +6.3% | 0.20% | -6.5% |
| Q2 2022 | $133,802,000 | +7.6% | 385,997 | +34.4% | 0.21% | +28.1% |
| Q1 2022 | $124,399,000 | +9417.9% | 287,268 | +11267.9% | 0.17% | +8250.0% |
| Q4 2021 | $1,307,000 | +2.3% | 2,527 | -4.1% | 0.00% | 0.0% |
| Q3 2021 | $1,277,000 | +87.0% | 2,635 | +73.8% | 0.00% | +100.0% |
| Q2 2021 | $683,000 | +11.2% | 1,516 | -63.5% | 0.00% | -50.0% |
| Q2 2018 | $614,000 | -95.3% | 4,150 | -95.2% | 0.00% | -93.9% |
| Q1 2018 | $13,132,000 | -76.3% | 86,941 | -79.6% | 0.03% | -75.4% |
| Q4 2017 | $55,319,000 | -19.8% | 427,006 | -25.1% | 0.13% | -64.0% |
| Q3 2017 | $68,944,000 | -4.6% | 570,301 | -7.3% | 0.37% | -7.5% |
| Q2 2017 | $72,284,000 | +12.5% | 615,187 | -2.7% | 0.40% | +6.9% |
| Q1 2017 | $64,273,000 | +10.3% | 632,301 | +11.5% | 0.38% | +7.7% |
| Q4 2016 | $58,294,000 | +1.4% | 566,901 | +8.0% | 0.35% | -2.8% |
| Q3 2016 | $57,476,000 | +10.4% | 524,894 | +13.7% | 0.36% | +22.1% |
| Q2 2016 | $52,064,000 | +8.5% | 461,681 | -9.0% | 0.29% | -32.4% |
| Q1 2016 | $47,964,000 | -5.1% | 507,444 | -9.7% | 0.44% | +38.5% |
| Q4 2015 | $50,568,000 | +105.1% | 561,862 | +110.7% | 0.31% | +109.3% |
| Q3 2015 | $24,652,000 | -8.1% | 266,620 | -2.1% | 0.15% | +3.4% |
| Q2 2015 | $26,815,000 | -32.8% | 272,320 | -31.5% | 0.14% | -31.0% |
| Q1 2015 | $39,895,000 | -6.1% | 397,800 | -13.5% | 0.21% | -3.2% |
| Q4 2014 | $42,504,000 | – | 460,000 | – | 0.22% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Broadcrest Asset Management, LLC | 275,000 | $18,719,250 | 20.14% |
| Montanaro Asset Management Ltd | 408,800 | $27,827,016 | 4.90% |
| Sandhill Capital Partners LLC | 613,061 | $41,731,091 | 3.90% |
| Pembroke Management, LTD | 365,611 | $24,887,141 | 3.40% |
| DF DENT & CO INC | 3,349,047 | $227,969,648 | 3.34% |
| Brown Capital Management | 3,158,004 | $214,965,332 | 3.30% |
| Ownership Capital B.V. | 1,786,273 | $121,591,603 | 3.05% |
| STONE RUN CAPITAL, LLC | 86,335 | $5,876,823 | 2.88% |
| Jackson Square Partners, LLC | 1,260,547 | $85,805,434 | 2.87% |
| Summit Creek Advisors LLC | 284,681 | $19,378,236 | 2.64% |